# Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus

> **NCT05631431** · PHASE2 · UNKNOWN · sponsor: **CuraLife** · enrollment: 120 (estimated)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Curalin

## Key facts

- **NCT ID:** NCT05631431
- **Lead sponsor:** CuraLife
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-15
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05631431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05631431, "Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05631431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*